期刊文献+

肠道病毒71型灭活疫苗滴度的酶联免疫吸附检测方法 被引量:5

An ELISA method for the titer determination of enterovirus 71 inactivated vaccine
原文传递
导出
摘要 目的 建立肠道病毒71型(EV71)灭活疫苗滴度的检测方法,用于疫苗研制及生产过程中抗原含量的测定.方法 以兔抗EV71多克隆抗体为包被抗体,小鼠抗EV71单克隆抗体为检测抗体,以夹心ELISA方法测量我们制备的EV71疫苗抗原参照品,建立抗原标准曲线,确定定量限度及最佳定量范围,同时验证该方法的特异性和可重复性.结果 建立了检测EV71抗原含量的夹心ELISA方法,定量限度为3.9352log10TCID50/mL,最佳定量范围为3.9352~5.9686 log10TCID50/mL,相关系数为R2=0.9956;特异性好,除与EV71疫苗样品有反应外,与其他样品无交叉反应;稳定性和重复性好,变异系数小于7%.结论 本研究建立的检测EV71灭活疫苗滴度的夹心ELISA方法灵敏、特异,为疫苗研制过程中抗原含量测定提供了快捷有效的检测手段. Objective To establish a quantitative assay method for determining the titer of enterovirus 71(EV71)during its inactivated vaccine development and manufacturing.Methods By using a mouse anti-EV71 monoclonal antibody and rabbit anti-EV71 polyclonal antibodies,a sandwich ELISA method for EV71 inactivated vaccine was established.The sensitivity,specificity and reproducibility of the method were evaluated.Results A specific and sensitive ELISA method for quantitative assay of EV71 inactivated vaccine was developed.Its detection limit was determined to be 3.9352 log10TCID50/mL and its detection range was 3.9352-5.9686 log10TCID50/mL.Its correlation coefficient was R2 =0.9956.The method showed good sensitivity,specificity and reproducibility.It had no cross-reaction to samples other than EV71 and the variation co-efficient was lower than 7%.Conclusions A quantitative ELISA method is established for EV71 inactivated vaccine.It offers a useful and rapid way to determine the titer of EV71 inactivated vaccine during its developnent and production.
出处 《国际流行病学传染病学杂志》 CAS 2011年第1期13-16,共4页 International Journal of Epidemiology and Infectious Disease
关键词 酶联免疫吸附测定 肠道病毒71型 灭活疫苗 Enzyme-linked immunosorbent assay Enterovirus 71 Inactivated vaccine
  • 相关文献

参考文献6

  • 1McMinn PC.An overview of the evolution of enterovirus 71 and its clinical and public health significance.FEMS Microbiol Rev,2002,26(1):91-107.
  • 2徐静,崔文禹,李树香,刘敬,王欣怡,陈蕾,沈心亮.肠道病毒71型抗原含量检测方法的建立及初步验证[J].中华实验和临床病毒学杂志,2009,23(5):388-390. 被引量:1
  • 3Li X,Mao C,Ma S,et al.Generation of neutralizing monoclonal antibodies against enterovirus 71 using synthetic peptides.Biochem Biophys Res Commun,2009,390(4):1126-1128.
  • 4徐宜.免疫检测技术.2版.北京:科学出版社,1997:167-182.
  • 5Liwry OH,Rosebrough NJ,Farr AL,et al.Protein measurement with the Folin phenol reagent.J.Biol Chem,193(1):265-275.
  • 6Miao LY,Pierce C,Gray-Johnson J,et al.Monoclonal antibodies to VP1 recognize a broad range of enteroviruses.J Clin Microbiol,2009,47(10):3108-3113.

二级参考文献6

  • 1金伯泉.细胞和分子免疫学实验技术.西安:第四军医大学出版社.2003:31-35.
  • 2徐宜.免疫检测技术.第2版.北京:科学出版社,1997:167-182.
  • 3Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis, 1974, 129:304-309.
  • 4Chung YC, Ho MS, Wu JC, et al.. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine, 2008, 26: 1855- 1862.
  • 5Liu CC, Lian WC, Butler M, et al. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine, 2007, 25:19-24.
  • 6Tung WS, Bakar SA, Sekawi Z, et al. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther, 2007,5 : 6.

同被引文献33

  • 1Yao-Chi Chung,Jen-Huang Huang,Chia-Wei Lai,Heng-Chun Sheng,Shin-Ru Shih,Mei-Shang Ho,Yu-Chen Hu.Expression,purification and characterization of enterovirus-71 virus-like particles[J].World Journal of Gastroenterology,2006,12(6):921-927. 被引量:43
  • 2Wang S M,Lei H Y,Yu C K,et al.Acute chemokine re-sponse in the blood and cerebrospinal fluid of children with en-terovirus 71-associated brainstem encephalitis[J].J Infect Dis,2008,198(7):1002.
  • 3Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol, 2010, 9(11 ):1097-1105.
  • 4McMinn PC. An overview of the evolution of enternvims 71 and its clinical and public health significance. FEMS Microbiol Rev, 2002, 26( 1 ): 91-107.
  • 5Lee MS, Chang LY. Development of enterovirus 71 vaccines. Expert Rev Vaccines, 2010, 9(2):149-156.
  • 6Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovims 71 vaccine in children in China: a muhicentre, randomised, double-blind, placebo-con- trolled, phase 3 trial. Lancet, 2013, 381(9882):2024-2032.
  • 7Foo DG, Alonso S, Phoon MC, et al. Identification of neutralizing linear epitopes from the VPI capsid protein of Enterovirus 71 using synthetic peptides. Virus Res, 2007, 125(1):61-68.
  • 8Foo DG, Alonso S, Chow VT, et al. Passive protection against lethal enterovirus 71 infection in new born mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect, 2007, 9(11):1299-1306.
  • 9Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiolo- gy, pathogenesis, and control of enterovirus 71 [ J ]. Lancet Infect Dis, 2010, 10(11) : 778 -790.
  • 10Gao F, Wang YP, Mao QY, st al. Enterovirus 71 viral capsid pro- tein linear epitopes: identification and characterization [ J ]. Virol J, 2012, 9(1) : 26.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部